Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors

The term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chrysi Galigalidou, Laura Zaragoza-Infante, Anastasia Iatrou, Anastasia Chatzidimitriou, Kostas Stamatopoulos, Andreas Agathangelidis
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/efa67e0fa42246998d881be6f07618f4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:efa67e0fa42246998d881be6f07618f4
record_format dspace
spelling oai:doaj.org-article:efa67e0fa42246998d881be6f07618f42021-11-11T04:42:52ZUnderstanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors2234-943X10.3389/fonc.2021.769612https://doaj.org/article/efa67e0fa42246998d881be6f07618f42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.769612/fullhttps://doaj.org/toc/2234-943XThe term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL shares a series of biological and clinical features with chronic lymphocytic leukemia (CLL), at least of the indolent type, and evolves to CLL requiring treatment at a rate of 1-2% per year, whereas ‘low-count’ MBL seems to be distinct, likely representing an immunological rather than a pre-malignant condition. That notwithstanding, both subtypes of MBL can carry ‘CLL-specific’ genomic aberrations such as cytogenetic abnormalities and gene mutations, yet to a much lesser extent compared to CLL. These findings suggest that such aberrations are mostly relevant for disease progression rather than disease onset, indirectly pointing to microenvironmental drive as a key contributor to the emergence of MBL. Understanding microenvironmental interactions is therefore anticipated to elucidate MBL ontogeny and, most importantly, the relationship between MBL and CLL.Chrysi GaligalidouChrysi GaligalidouLaura Zaragoza-InfanteLaura Zaragoza-InfanteAnastasia IatrouAnastasia ChatzidimitriouAnastasia ChatzidimitriouKostas StamatopoulosKostas StamatopoulosAndreas AgathangelidisAndreas AgathangelidisFrontiers Media S.A.articlemonoclonal B cell lymphocytosis (MBL)chronic Lymphocutic Leukemia (CLL)geneticsimmunogeneticstumor microenvironmentontogenesisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic monoclonal B cell lymphocytosis (MBL)
chronic Lymphocutic Leukemia (CLL)
genetics
immunogenetics
tumor microenvironment
ontogenesis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle monoclonal B cell lymphocytosis (MBL)
chronic Lymphocutic Leukemia (CLL)
genetics
immunogenetics
tumor microenvironment
ontogenesis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Chrysi Galigalidou
Chrysi Galigalidou
Laura Zaragoza-Infante
Laura Zaragoza-Infante
Anastasia Iatrou
Anastasia Chatzidimitriou
Anastasia Chatzidimitriou
Kostas Stamatopoulos
Kostas Stamatopoulos
Andreas Agathangelidis
Andreas Agathangelidis
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
description The term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL shares a series of biological and clinical features with chronic lymphocytic leukemia (CLL), at least of the indolent type, and evolves to CLL requiring treatment at a rate of 1-2% per year, whereas ‘low-count’ MBL seems to be distinct, likely representing an immunological rather than a pre-malignant condition. That notwithstanding, both subtypes of MBL can carry ‘CLL-specific’ genomic aberrations such as cytogenetic abnormalities and gene mutations, yet to a much lesser extent compared to CLL. These findings suggest that such aberrations are mostly relevant for disease progression rather than disease onset, indirectly pointing to microenvironmental drive as a key contributor to the emergence of MBL. Understanding microenvironmental interactions is therefore anticipated to elucidate MBL ontogeny and, most importantly, the relationship between MBL and CLL.
format article
author Chrysi Galigalidou
Chrysi Galigalidou
Laura Zaragoza-Infante
Laura Zaragoza-Infante
Anastasia Iatrou
Anastasia Chatzidimitriou
Anastasia Chatzidimitriou
Kostas Stamatopoulos
Kostas Stamatopoulos
Andreas Agathangelidis
Andreas Agathangelidis
author_facet Chrysi Galigalidou
Chrysi Galigalidou
Laura Zaragoza-Infante
Laura Zaragoza-Infante
Anastasia Iatrou
Anastasia Chatzidimitriou
Anastasia Chatzidimitriou
Kostas Stamatopoulos
Kostas Stamatopoulos
Andreas Agathangelidis
Andreas Agathangelidis
author_sort Chrysi Galigalidou
title Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
title_short Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
title_full Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
title_fullStr Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
title_full_unstemmed Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
title_sort understanding monoclonal b cell lymphocytosis: an interplay of genetic and microenvironmental factors
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/efa67e0fa42246998d881be6f07618f4
work_keys_str_mv AT chrysigaligalidou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT chrysigaligalidou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT laurazaragozainfante understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT laurazaragozainfante understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT anastasiaiatrou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT anastasiachatzidimitriou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT anastasiachatzidimitriou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT kostasstamatopoulos understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT kostasstamatopoulos understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT andreasagathangelidis understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
AT andreasagathangelidis understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors
_version_ 1718439642889453568